MD-reviewed ·  Healthcare editorial
MedAI Verdict
Pathology

Reference AS-081  ·  AI Pathology

Mindpeak

by Mindpeak  ·  DE

AI for IHC breast/colon cancer scoring.

At a glance

Pricing
Enterprise.
HIPAA
Not disclosed
SOC 2
Not disclosed
EHRs
Founded
HQ
DE

Bottom line

AI for IHC breast/colon cancer scoring.

Free tier available.

Overview

IHC breast/colon scoring. Integrated with PathAI and Lumea.

Pricing

What it costs

Free tier only; no paid plans publicly disclosed.

TierMonthlyAnnualNotes
PlanEnterprise.

Source: vendor pricing page. Verified May 23, 2026.

Peer-reviewed coverage

What the literature says

2 peer-reviewed studies indexed on PubMed evaluate Mindpeak in clinical contexts. The most relevant are shown below, ranked by editorial relevance score combining title match, study design, recency, and journal tier.

Analytical Comparison of Commonly Used Laboratory-Developed Tests for the Assessment of Ki-67 in Breast Carcinoma With a Food and Drug Administration-Approved Benchmark.
Badve S, White JS, Sapunar F, et al.· Mod Pathol· 2025Observational
Ki-67 immunohistochemistry (IHC), a commonly used assay for breast cancer risk prognostication, has significant interlaboratory heterogeneity. This study assessed the impact of antibody clones by comparing the Ki-67 IHC MIB-1 pharmDx assay (Dako Omnis; Agilent Technologies) with clones MIB-1 (Dako Autostainer Link 48 platform), K2 (Leica BOND-III platform), and 30-9 (Ventana BenchMark ULTRA platform) used in Ki-67 laboratory-developed IHC tests. Breast cancer tissue microarrays were processed and stained in 2 central laboratories per the manufacturer's instructions. Digitized images were asse…
Ki-67 Quantification in Breast Cancer by Digital Imaging AI Software and its Concordance with Manual Method.
Zehra T, Shams M, Ahmad Z, et al.· J Coll Physicians Surg Pak· 2023
To validate the concordance of automated detection of Ki67 in digital images of breast cancer with the manual eyeball / hotspot method. Descriptive study. Place and Duration of the Study: Jinnah Sindh Medical University, Karachi, from 1st January to 15th February 2022. Glass slides of cases diagnosed as invasive ductal carcinoma (IDC) were obtained from the Agha Khan Medical University Hospital, selected retrospectively and randomly from 60 patients. They were stained with the Ki67 antibody. An expert pathologist evaluated the Ki67 index in the hotspot fields using eyeball method. Digital ima…

See all on PubMed